Varicella zoster virus envelope glycoproteins — Drug Target
All drugs that target Varicella zoster virus envelope glycoproteins — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- varicella zoster virus · AstraZeneca · Live attenuated viral vaccine · Immunology / Infectious Disease
Varicella zoster virus (VZV) is a live attenuated viral vaccine that stimulates immune response to prevent chickenpox and herpes zoster infections.